Immunocytochemistry: An indispensable technique in routine cytology

Cytopathology

Volumn 22, Issue 4, 2011, Pages 215-229

  Skoog, L ^a   Tani, E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell blocks; Cytological specimens; Cytomorphology; Cytospins; Immunocytochemistry; Immunocytology; Liquid based cytology; Targeted therapy; Theranostics

Indexed keywords

ACETONE; ACTIN; ALCOHOL; ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CALCITONIN; CALRETININ; CARCINOEMBRYONIC ANTIGEN; CD45 ANTIGEN; CELL NUCLEUS ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; FORMALDEHYDE; HBME 1 PROTEIN; KI 67 ANTIGEN; MEMBRANE ANTIGEN; METHANOL; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TUMOR PROTEIN; UNCLASSIFIED DRUG; WILM TUMOR PROTEIN 1;

ADENOCARCINOMA; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CELL PROLIFERATION; CELL SUSPENSION; CLEAR CELL SARCOMA; CONTROL GROUP; CYTODIAGNOSIS; DATA ANALYSIS; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIAGNOSTIC ACCURACY; EWING SARCOMA; FLOW CYTOMETRY; GOOD LABORATORY PRACTICE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY TEST; LEIOMYOSARCOMA; LYMPHOBLASTOMA; LYMPHOMA; MESOTHELIOMA; MESOTHELIUM CELL; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REVIEW; RHABDOMYOSARCOMA; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STORAGE TEMPERATURE; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ANTIBODIES; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; REFERENCE STANDARDS; SPECIMEN HANDLING; STAINING AND LABELING; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 79960535696     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2011.00887.x     Document Type: Review

References (78)

1. Fetsh P, Simsir A, Brosky K, Abati A. Comparison of three commonly used cytology preparations in effusion immunocytochemistry. Diagn Cytopathol 2002;26:61-7.
2. Wiatrowska B, Berner A, Torlakovic G et al. Cutured anaplastic cell lines as immunocytochemistry controls. Diagn Cytopathol 2001;25:303-10.
3. Tani EM, Borregon A, Humla S, Skoog L. Estrogen receptors in fine needle aspirates from metastatic lesions of gynecologic tumors. Gynecol Oncol 1989;32:365-7.
4. Skoog L, Humla S, Isaksson S, Tani EM. Immunocytochemical analysis of receptors for estrogen and progesterone in fine needle aspirates from human mammary carcinomas. Diagn Cytopathol 1990;6:95-8.
5. Skoog L, Tani E, Svedmyr E, Johansson B. Growth fraction in non Hodgkin's lymphomas and reactive lymphadenitis determined by Ki-67 monoclonal antibody in fine needle aspirates. Diagn Cytopathol 1995;12:234-40.
6. Suthipintawong C, Leong AS, Chan KW, Vinyuvat S. Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: a simplified method with formalin fixation. Diagn Cytopathol 1997;17:127-33.
7. Abati A, Fetsch P, Filie A. If cells could talk. The application of new techniques to cytopathology. Clin Lab Med 1998;18:561-83.
8. Gong Y, Symmans WF, Krishnamurthy S, Patel S, Sneige N. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma. Cancer 2004;102:34-40.
9. Tabbara SO, Sidaway M, Frost AR et al. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides. Cancer Cytopathol 1998;84:355-60.
10. Suthipintawong C, Leong A-Y, Vinyuvat S. Immunostaining of cell preparations: a comparative evaluation of common fixatives and protocols. Diagn Cytopathol 1996;15:167-74.
11. Tani EM, Christensson B, Porwit A, Skoog L. Immunocytochemical analysis and cytomorphologic diagnosis on fine-needle aspirates of lymphoproliferative disease. Acta Cytol 1988;32:209-15.
12. Shin SJ, Chen B, Hyjek E, Vazquez M. Immunocytochemistry and fluorescence in situ hybridization in HER-2/neu status in cell block preparations. Acta Cytol 2007;51:552-7.
13. Bathia P, Dey P, Uppal R et al. Cell blocks from scraping of cytology smear: comparison with conventional cell block. Acta Cytol 2008;52:329-33.
14. Kulshrestha R, Vijayan VK. Immunohistochemical staining on fine needle aspiration biopsy-cell block speciments in the differential diagnosis of lung cancers. Indian J Chest Dis Allied Sci 2009;51:21-5.
15. Varsegi GM, Shidham V. Cell block preparation from cytology specimen with predominance of individually scattered cells. J Vis Exp 2009;21:1316.
16. Young NA, Al-Saleem TI, Ehya H, Smith MR. Utilization of fine needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma. Cancer Cytopathol 1998;84:252-61.
17. Cornfield DB, Mitchell DM, Almasri NM et al. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20. Am J Clin Pathol 2000;114:258-63.
18. Kussick SJ, Kalnoski M, Braziel RM, Wood BL. Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 2004;121:464-72.
19. Sigstad E, Dong HP, Davidson B et al. The role of flow cytometric immunophenotyping in improving the diagnostic accuracy in referred fine-needle aspiration specimens. Diagn Cytopathol 2004;31:159-63.
20. Zeppa P, Marino G, Troncone G et al. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions. Cancer 2004;102:55-65.
21. Laane E, Tani E, Björklund E et al. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Cytometry B Clin Cytom 2005;64:34-42.
22. Demurtas A, Accinelli G, Pacchionei D et al. Utility of flow cytometry immunophenotyping in fine-needle aspirate cytologic diagnosis of non-Hodgkin lymphoma: a series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol 2010;18:311-22.
23. Dabbs DJ, Abendroth CS, Grenko RT et al. Immunochemistry on the ThinPrep processor. Diagn Cytopathol 1997;17:388-92.
24. Kaplan MA, Segura AM, Wang HH et al. Evaluation of Cytolyt and PreservCyt as preservatives for immunocytochemistry for cytokeratin in fine needle aspiration. Appl Immunohistochem Mol Morphol 1998;6:23-9.
25. Fadda G, Rossi E, Mulé A et al. Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology. Acta Cytol 2006;50:129-35.
26. Dejmek A, Hjerpe A. Immunohistochemical reactivity in mesothelioma and adenocarcinoma: a stepwise logistic regression analysis. APMIS 1994;102:255-64.
27. Delahaye M, van der Ham F, van der Kwast TH. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions. Diagn Cytopathol 1997;17:115-20.
28. Davidson B. The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma. Cytopathology 2011;22:5-21.
29. Yuan Y, Nymoen DA, Tuft Satvnes H et al. Tenascin-X is a novel diagnostic marker of malignant mesothelioma. Am J Surg Pathol 2009;33:1673-82.
30. Ascoli V, Carnovale-Scalzo C, Taccogna S, Nardi F. Utility of HBME-1 immunostaining in serous effusions. Cytopathology 1997;8:328-35.
31. Bassarova AV, Nesland JM, Davidson B. D2-40 is not a specific marker for cells of mesothelial origin in serious effusions. Am J Surg Pathol 2006;30:878-82.
32. Saad RS, Lindner JL, Lin X et al. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement. Diagn Cytopathol 2006;34:801-6.
33. Hecht JL, Lee BH, Pinkus GS. The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma. Cancer 2002;96:105-9.
34. Ordoñez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998;22:1215-21.
35. Singh HK, Silverman JF, Berns L et al. Significance of epithelial membrane antigen in the work-up of problematic serous effusions. Diagn Cytopathol 1995;13:3-7.
36. Motherby H, Kube M, Friedrichs N et al. Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears. Anal Cell Pathol 1999;19:7-20.
37. Yaziji H, Battifora H, Barry TS et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006;19:514-23.
38. Hecht JL, Pinkus JL, Weinstein LJ et al. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001;116:483-8.
39. Afify AM, al-Khafaji BM. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Acta Cytol 2002;46:675-8.
40. Shen J, Pinkus GS, Deshpande V, Cibas ES. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol 2009;131:516-23.
41. Hasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010;118:90-6.
42. Su XY, Li GD, Liu WP, Xie B, Jiang YH. Cytological differential diagnois among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol 2010. Epub ahead of print.
43. Saleh H, Bober P. Value of Ki67 immunostain in identification of malignancy in serous effusions. Diagn Cytopathol 1999;20:24-8.
44. Sack MJ, Roberts SA. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinomas in cytologic specimens. Cytopathology 1997;16:132-6.
45. Saad RS, Essig DL, Silverman JF et al. Diagnostic utility of CDX2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks. Cancer 2004;102:168-73.
46. Levine PH, Joutovsky A, Cangiarella J et al. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma. Diagn Cytopathol 2006;34:191-5.
47. Kobayashi M, Ueyama Y, Nakanishi H et al. Immunocytochemical detection using CDX2: an aid for discerning tumor involvement in ascites cytology. Cancer 2006;108:114-8.
48. Dabbs DJ, Landreneau RJ, Liu Y et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg 2002;73:403-5. discussion 406.
49. Fan CY, Wang J, Barnes EL. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol 2000;24:579-86.
50. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Am J Clin Pathol 2003;119:801-6.
51. Fiel MI, Cernaianu G, Burstein DE et al. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Acta Cytol 1996;40:637-41.
52. Striebel JM, Dacic S, Yousem SA. Gross cystic disease fluid protein-(GCDFP-15): expression in primary lung adenocarcinoma. Am J Surg Pathol 2008;32:426-32.
53. Skoog L, Tani E. FNA cytology in the diagnosis of lymphoma. In: Monograms in Clinical Cytology. Orell SR (ed.). Basel: Karger; 2009; 18: pp. 1-4.
54. Ramani P, Rampling D, Link M. Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity. Histopathology 1993;23:557-61.
55. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Retting WL. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991;139:317-25.
56. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22:673-82.
57. Kodet R. Rhabdomyosarcoma in childhood. An immunohistological analysis with myoglobin, desmin and vimentin. Pathol Res Pract 1989;185:207-13.
58. Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995;147:1799-810.
59. Coffin CM, Rulon J, Smith L et al. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol 1997;10:1175-87.
60. Miettinen M, Chatten J, Paetau A, Stevenson A. Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol 1998;22:327-32.
61. Fröstad B, Tani E, Kogner P et al. The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours. Eur J Cancer 1998;34:529-36.
62. Fröstad B, Tani E, Brosjö O, Skoog L, Kogner P. Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor. Med Pediatr Oncol 2002;38:33-40.
63. Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison. Am J Surg Pathol 2001;25:1290-6.
64. Perlman E, Grosfeld JL, Togashi K, Boccon-Gibod L. Pathology and genetics of tumors of the urinary system and male genital organs. In: World Health Organization Classification of Tumours. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). Lyon, France: IARC Press; 2004: pp. 48-52.
65. Zhang PJ, Goldblum JR, Pawel BR et al. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 2003;16:229-35.
66. Lae ME, Roche PC, Jin L et al. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 2002;26:823-35.
67. Ordonez NG. Desmoplastic small round cell tumor I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol 1998;22:1303-13.
68. Löfgren L, Skoog L, von Shoultz E et al. Hormone receptor status in breast cancer - a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 2003;14:136-42.
69. Komatsu K, Nakanishi Y, Seki T et al. Application of liquid-based preparation to fine needle aspiration cytology in breast cancer. Acta Cytol 2008;52:591-6.
70. Willmore-Payne C, Layfield LJ, Holden JA. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. Cancer 2005;105:165-70.
71. Vocaturo A, Novelli F, Benevolo M et al. Chromogenic in situ hybridization to detect HER 2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab era. Oncologist 2006;11:878-86.
72. Bozzetti C, Nizzoli R, Guazzi A et al. HER 2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer. Ann Oncol 2002;13:1398-403.
73. Billgren A-M, Rutquist LE, Tani E et al. Proliferating fraction during neo adjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse free survival. Acta Oncol 1999;38:597-601.
74. Sahebali S, Depuydt CE, Boulet GA et al. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer 2006;118:1254-60.
75. Pallesen G, Hamilton-Dutoit SJ, Rowe M et al. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991;337:320-2.
76. Herndier BG, Sanchez HC, Chang Kl et al. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 1993;142:1073-9.
77. Goel MM, Budwar P. Species-specific immunocytochemical localization of Mycobacterium tuberculosis complex in fine needle aspirates of tuberculous lymphadenitis using antibody to 38 kCa immunodominant protein antigen. Acta Cytol 2008;52:424-33.
78. Braz-Silva PH, Magalhães MH, Hofman V et al. Usefulness of oral cytopathology in the diagnosis of infectious diseases. Cytopathology 2010;21:285-99.